Murata Vios, Inc. FDA Recalls

4 recalls on file across devices, 0 of them Class I and 3 still open. This firm is not matched to a listed company.

Newest first

Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.

Product	Reason	Class	Initiated
Vios Monitoring System Bedside Monitor Model BSM2050Class IIAug 9, 2024Batteries may deplete over time while not in use if devices	Batteries may deplete over time while not in use if devices are stored without being plugged in to wall outlet	Class IIDevices	Aug 9, 2024
muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rateClass IIApr 22, 2024During the set-up and workflow to begin Vios monitoring, it	During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG	Class IIDevices	Apr 22, 2024
Vios Monitoring System Bedside Monitor, Model BSM2050, Software Version Numbers 1.54.20 and 1.56.00Class IIJun 6, 2023A premature failure condition was identified with the L2050R	A premature failure condition was identified with the L2050R pulse oximeter SpO2 sensor that connects to the L	Class IIDevices	Jun 6, 2023
muRata Vios Monitoring System Model 2050; bedside cardiac monitor, including cardiotachometer and alarm rateClass IIJun 21, 2021During the set-up and workflow to begin Vios monitoring, it	During the set-up and workflow to begin Vios monitoring, it has been noticed that patient vital signs and ECG	Class IIDevices	Jun 21, 2021